On Jun 8, we issued an updated research report on CVS Health CVS. While increasing demand for PBM (Pharmacy Benefit Management) and specialty pharmacy was a major growth driver for the stock, its dull retail performance over the last few quarters seems to have disappointed investors. The company carries a Zacks Rank #3 (Hold).
CVS Health's PBM Selling Season Remains Solid, Retail Grows
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться